Skip to content

Use of eHealth in Communication With Patients About Prenatal Diagnosis

Use of eHealth in Communication With Patients About Prenatal Diagnosis. An Intervention Study Carried Out in a Highly Specialised Unit for Obstetrics

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01889550
Acronym
HIIP
Enrollment
1150
Registered
2013-06-28
Start date
2013-08-31
Completion date
2014-08-31
Last updated
2014-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Downs Syndrome, Health Knowledge, Attitudes, Practice

Keywords

Screening, Downs syndrome, Informed choice, eHealth

Brief summary

The research aims at generating new knowledge about ways to inform pregnant women about prenatal screening for Downs syndrome. The overall purpose of this project is to increase pregnant women's knowledge of prenatal screening for Downs syndrome, and thereby an option to make an informed choice. The project is planned as a research into whether the use of an eHealth solution (in this project an interactive website) may be an appropriate intervention for pregnant women.

Detailed description

Prenatal screening and diagnosis is testing for diseases or rare conditions in the fetus before birth. The aim is to assist the pregnant women to make their own decisions, and neutral and adequate counseling is a prerequisite during prenatal diagnosis. To make an informed choice, the pregnant women must be informed about the benefits and potential disadvantages of prenatal diagnosis and with this background be able to make a comprehensive evaluation, where ethical values will have a high impact. The overall purpose of this project is to increase pregnant women's knowledge of prenatal screening for Downs syndrome, and thereby an option to make an informed choice. The project is planned as a research into whether the use of an eHealth solution (in this project an interactive website) may be an appropriate intervention for pregnant women. Methods: Part one consists of an identification of the problem Part two consists of developing a website with relevant information about prenatal screening for Downs syndrome. Part three is an effect measurement. The effect of the intervention is measured through a randomized controlled trail in which the essentials of the measurement will be the pregnant women's knowledge and behavior in relation to prenatal diagnosis. Twice 300 pregnant women will be included in the project. Results: The research aims at generating new knowledge about ways to inform pregnant women about prenatal diagnosis and prenatal screening. The expected results are: * Higher knowledge about prenatal diagnosis for the pregnant women. * Less difficulty in making an informed choice for the coming parents. * Easy access to high quality information. * Equity in access to high quality information.

Interventions

BEHAVIORALAccess to the website www.graviditetsportalen.dk

The website www.graviditetsportalen.dk contains information about the screeningtest for Downs syndrome. The website uses both text, video and animated graphics.

BEHAVIORALAccess to the website www.ouh.dk

Access to the usual information from the hospital website

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant women participating in screening for Downs syndorme

Exclusion criteria

* Respondents who do not speak, read and understand Danish. * Respondents who have opted out of health care services and prenatal diagnosis. * Reespondenter who do not wish to participate. * Respondents under 18 years. * Respondents with a strong suspicion of threatening abortion * Respondents whom are vulnerable * Respondents with a late referral

Design outcomes

Primary

MeasureTime frameDescription
Multidimensional measure of informed choice (MMIC)Participants will be asked to compleete the questionnaire in an expected average of 6 weeks after having had the nuchal translucency scan.Questionnaire for assessing knowledge of prenatal screening for Downs syndrome

Secondary

MeasureTime frame
Decisional Conflict ScaleParticipants will be asked to compleete the questionnaire in an expected average of 6 weeks after having had the nuchal translucency scan.
WHO well-being indexParticipants will be asked to compleete the questionnaire in an expected average of 6 weeks after having had the nuchal translucency scan.
Cambridge Worry ScaleParticipants will be asked to compleete the questionnaire in an expected average of 6 weeks after having had the nuchal translucency scan.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026